Neurotech International 2026 Annual Report12026 Annual Repor tNeurotech International 2026 Annual ReportNeurotech International 2026 Annual Report112Chairman’s Letter 2Directors’ Report 6Auditor’s Independence Declaration 28Financial Statements 30Consolidated Statement 31 of Pro?t or Loss...
Annual Report (Typeset)
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- Notice of Annual General Meeting/Proxy Form
- NTI Doses First Patient in Phase 3 Beyond Harmony ASD Study
- Initial Director's Interest Notice
- Notification of cessation of securities - NTI
- Board and Management Changes
Later from Neurotech International
- Change of Director's Interest Notice
- Becoming a substantial holder
- Corporate Presentation
- Ceasing to be a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International